Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well IBI308 combined with paclitaxel/albumin-bound paclitaxel
work in treating participants with small cell lung cancer after failing to platinum-etoposide
chemotherapy.